FOXO1 and rhabdomyosarcoma: Importantly, the neural gene expression profiles induced by PAX3-FOXO1 closely match those observed in clinical rhabdomyosarcoma samples, particularly post-chemotherapy, suggesting a role in therapy resistance [206].